Zhen Zhang

1PUBLICATIONS
13CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells.

Zhen Zhang, Marlene Langenbach, Sagar Sagar

Pageof 1

Frequent Collaborators

1 joint publications

Sagar Sagar

1 joint publications

Viktor Fetsch

1 joint publications

Saskia Lehr

1 joint publications

Reinhard E Voll

1 joint publications

Christoph Neumann-Haefelin

1 joint publications

Tobias Boettler

1 joint publications

Maike Hofmann

1 joint publications

Melanie Boerries

1 joint publications

Frank Meiss

1 joint publications

Robert Zeiser

Frequent Collaborators

1 joint publications

Sagar Sagar

1 joint publications

Viktor Fetsch

1 joint publications

Saskia Lehr

1 joint publications

Reinhard E Voll

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

8.9K
See more related videos

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

8.9K
See more related videos